ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 237,204 Value ($000) $3,653 Avg Close $19.92 Range $15.14 - $24.64

Q3 2025

Shares 262,272 Value ($000) $5,369 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 189,505 Value ($000) $3,801 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 211,752 Value ($000) $4,167 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 131,246 Value ($000) $2,953 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 121,785 Value ($000) $3,110 Avg Close $23.16 Range $20.63 - $27.67

Q2 2024

Shares 65,753 Value ($000) $1,537 Avg Close $21.05 Range $15.96 - $26.00

Q1 2024

Shares 17,273 Value ($000) $304 Avg Close $15.34 Range $10.90 - $19.50

Q4 2023

Shares 22,698 Value ($000) $314 Avg Close $12.23 Range $9.80 - $15.41

Q3 2023

Shares 17,690 Value ($000) $242 Avg Close $16.84 Range $12.38 - $20.77

Q2 2023

Shares 27,286 Value ($000) $557 Avg Close $20.21 Range $17.15 - $23.98

Q1 2023

Shares 41,411 Value ($000) $907 Avg Close $20.34 Range $14.56 - $25.34

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	237,204	$3,653	$19.92	$15.14 - $24.64
Q3 2025	262,272	$5,369	$20.16	$17.43 - $24.38
Q2 2025	189,505	$3,801	$18.93	$13.30 - $24.11
Q1 2025	211,752	$4,167	$21.52	$18.67 - $25.37
Q4 2024	131,246	$2,953	$25.92	$21.43 - $30.03
Q3 2024	121,785	$3,110	$23.16	$20.63 - $27.67
Q2 2024	65,753	$1,537	$21.05	$15.96 - $26.00
Q1 2024	17,273	$304	$15.34	$10.90 - $19.50
Q4 2023	22,698	$314	$12.23	$9.80 - $15.41
Q3 2023	17,690	$242	$16.84	$12.38 - $20.77
Q2 2023	27,286	$557	$20.21	$17.15 - $23.98
Q1 2023	41,411	$907	$20.34	$14.56 - $25.34